Cargando…
Children with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension Treated with Pulmonary Vasodilators—The Pediatric Cardiologist Point of View
Pulmonary hypertension in children with bronchopulmonary dysplasia (BPD-PH) significantly worsens the prognosis. Pulmonary vasodilators are often used in BPD-PH but the short-term outcome of treatment is not well described. The aim of this study was to evaluate BPD-PH children diagnosed beyond 36 we...
Autores principales: | Migdał, Anna, Sądel-Wieczorek, Anna, Ryciak, Edyta, Mirecka-Rola, Alicja, Brzezińska-Rajszys, Grażyna, Żuk, Małgorzata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145230/ https://www.ncbi.nlm.nih.gov/pubmed/33922327 http://dx.doi.org/10.3390/children8050326 |
Ejemplares similares
-
Six-Minute Walk Test in Evaluation of Children with Pulmonary Arterial Hypertension
por: Zuk, Malgorzata, et al.
Publicado: (2017) -
Usefulness of Red Cell Width Distribution (RDW) in the Assessment of Children with Pulmonary Arterial Hypertension (PAH)
por: Zuk, Malgorzata, et al.
Publicado: (2019) -
Which Functional Classification Scale is Optimal for Children with Pulmonary Hypertension (PAH)?
por: Migdał, Anna, et al.
Publicado: (2020) -
Outpatient prescription of pulmonary vasodilator therapy to preterm children with bronchopulmonary dysplasia
por: Jeremiasen, Ida, et al.
Publicado: (2022) -
Pulmonary Biomarkers of Bronchopulmonary Dysplasia
por: Thompson, Alecia, et al.
Publicado: (2008)